> News > Industry News

Industry News

Why Is Sodium Hypochlorite Still a Powerful Choice for Modern Water Treatment

Leache has more than 40 years of experience in water treatment chemicals and supplies Sodium Hypochlorite for drinking water, swimming pools, wastewater systems, industrial cooling towers, and other disinfection applications. With customers in more than 60 countries, Leache focuses on practical, rel......

Why Is N-Bromosuccinimide a Critical Reagent in Modern Chemical Synthesis and Pharmaceutical Development?

In the world of organic chemistry, few reagents offer the versatility and precision of N-Bromosuccinimide. This white to pale yellow crystalline compound serves as a cornerstone for bromination reactions, radical processes, and oxidation transformations across multiple industries. Its applications r......

Why Is 1,3-Dihydroxymethyl-5,5-Dimethylhydantoin a Critical Building Block in Pharmaceutical Synthesis?

In pharmaceutical manufacturing, the quality of intermediates directly impacts the safety, efficacy, and cost-efficiency of final drug products. 1,3-Dihydroxymethyl-5,5-Dimethylhydantoin (also known as DMH or 1-HMH) is a versatile hydantoin derivative widely used as a pharmaceutical intermediate an......

What Makes the Type2 AC Charging Cable the Standard Choice for European EV Charging?

As electric vehicles continue to gain market share across Europe, the demand for reliable, standardized charging solutions has never been greater. The Type2 AC Charging Cable has become the de facto standard for AC charging in most European countries, offering a safe, efficient, and widely compatibl......

What Industrial & Pharma Uses Does High-Purity 5-Isobutyl Hydantoin Provide?

High-purity hydantoin intermediates are core raw materials for drug synthesis, green agrochemicals and functional polymer production. 5-Isobutyl Hydantoin (CAS 616-04-6) manufactured by Leache Chem is white crystalline powder with ≥99.5 purity, stable chemical index and wide compatibility with vario......

What Is the Regulatory Status of Hydantoin Pharmaceutical Intermediates for Antiepileptic Drug Manufacturing?

A common misconception is that Hydantoin Pharmaceutical Intermediates receive the same approvals as finished medicines. In reality, the regulatory framework is more nuanced. Pharmaceutical intermediates are generally not approved as finished therapeutic products.

<1 2 3 4 5...10 >